Immediate Impact
11 hit
Citing Papers
Small Cell Lung Cancer
2025 Hit
Metabolic reprogramming in cancer: Mechanisms and therapeutics
2023 Hit
Works of Edem Agamah being referenced
SWOG S1929: Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer (ES-SCLC).
2023
Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium
2010